Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • Andrew.G
    Junior Member
    • Sep 2016
    • 6

    Odd fragmentation patterns using a Bioruptor for sonication

    I am trying to create a genomic library for transposon integration profiling in yeast.
    Recently I have been getting a very strange fragmentation pattern. It seems that my fragmentation is at the same time too high and too low.
    I am currently shearing for 13 cycles, 3 sets of 3, and one set of 4 for 30 seconds on and 30 seconds off. Others using this protocol for different organisms have gotten great fragmentation with a peak at ~350bp, which is what I am aiming for. I have seen this in the last few samples Ive been using to optimize my procedure. At first I thought that maybe consecutive freeze thaws or DNase contamination may be the problem, but even using samples isolated from the night before and immediately put into the -20 showed this fragmentation, despite two attempts.

    A quick rundown of my protocol is using zymolase then the epicenter kit to break open the cells and precipitate most of the protein. From there I treat with RNase A for 1 hr, proteinase k for 2 hours, a phenol chlor extraction, chlor back extraction, and finally an ethanol precipitation. The sample on this BioA had 6 ethanol washes in the ethanol precipitation.

    Attached is a BioA of my most recent attempt. the first 8 samples are mine the others belong to someone who was sharing the run with me.
    The key is the first 4 samples are from one isolation at 300-600 ng of total DNA increasing by 100 ng per sample. The second 4 samples are the same setup just from a different isolation.

    If anyone has any advice on how to improve my fragmentation or an explanation of what could be causing the strange fragmentation pattern I would be very appreciative.
    Andrew
    Attached Files
  • Iva
    Junior Member
    • Aug 2016
    • 3

    #2
    I have just started doing RNAseq and had to use Bioruptor Pico for fragmentation; I only had 4 samples to test the protocol prior to the real deal (I aimed at 300bp fragments). In the protocol for Bioruptor they point out that you should spin briefly halfway through the sonication if you are aiming at larger fragments (>300bp). I split my 4 samples into two groups so I sonicated one group without spinning halfway through and the other group with the short spin. I saw something quite similar to your Bioanalyser High Sensitivity DNA traces in the group that wasn't spun (don't have the pdf on me atm). The group with short spin looked perfect in all runs.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
      by SEQadmin2


      Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

      The systematic characterization of the human proteome has
      ...
      Today, 11:48 AM
    • SEQadmin2
      Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
      by SEQadmin2



      Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
      ...
      07-09-2026, 11:10 AM
    • SEQadmin2
      Cancer Drug Resistance: The Lingering Barrier to Rising Survival
      by SEQadmin2



      Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

      There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
      07-08-2026, 05:17 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, Today, 11:10 AM
    0 responses
    7 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-13-2026, 10:26 AM
    0 responses
    29 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-09-2026, 10:04 AM
    0 responses
    38 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-08-2026, 10:08 AM
    0 responses
    25 views
    0 reactions
    Last Post SEQadmin2  
    Working...